NCT02786017 - Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Decompensated Cirrhosis

Interventions

BIOLOGICAL

Conventional therapy

Patients will receive the conventional therapy.

BIOLOGICAL

Injectable Collagen Scaffold + HUC-MSCs

Injectable collagen scaffold combined with HUC-MSCs was injected into left lateral segment, left medial segment, right anterior segment, right posterior segment and caudate lobe under B-mode ultrasound supervision, respectively. The total amount of HUC-MSCs was 5\*10\^8.

Trial Locations (1)

210008

RECRUITING

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing